Conditions That Respond to Anti-Inflammatory Peptide Therapy Peptide therapy for inflammation shows promise across a diverse range of conditions
Interestingly, the ability of TRX-m1 to promote GSAAT activity was lower than that of TRX-f1, as suggested above ( Figure 2D )
On other hand, prooxidant therapies, including ionizing radiation and chemotherapeutic agents, are widely used in clinics, based on the rationale that a further oxidative stimulus added to the constitutive oxidative stress in tumor cells should, in fact, cause the collapse of the antioxidant systems, leading to cell death [6]
Similarly, specialized laboratory testing can assess markers of oxidative stress and glutathione status, potentially allowing for more targeted protocols based on actual deficiencies rather than presumed needs